Ampersand Capital Partners Acquires Purna Pharmaceuticals
February 12, 2026
Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider for liquid and semi-solid pharmaceutical dosage forms. The investment is intended to enable collaboration with Ampersand portfolio company MedPharm to build a trans-Atlantic topical and transdermal drug formulation and manufacturing partnership for global pharmaceutical clients.
- Buyers
- Ampersand Capital Partners
- Targets
- Purna Pharmaceuticals
- Sellers
- Creafund
- Platforms
- MedPharm
- Industry
- Healthcare Services
- Location
- Flemish Region, Belgium
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.